Back to 
WELLS FARGO & COMPANY/MN
WELLS FARGO & COMPANY/MN
RNAZ2 quarters
Position history for WELLS FARGO & COMPANY/MN's holdings in TRANSCODE THERAPEUTICS INC
WELLS FARGO & COMPANY/MN holds 55 shares of RNAZ (TRANSCODE THERAPEUTICS INC), worth $342 as of 2026-Q2.
Current Value
$342
Current Shares
55
Total Value Change
-$132
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of RNAZ: GOLDMAN SACHS GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, VANGUARD CAPITAL MANAGEMENT LLC